Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative stress.
Oral coenzyme Q10 supplementation in patients with non-alcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3 insulin resistance and oxidative stress